Mitochondrial disorders in NSAIDs-induced small bowel injury

Journal of Clinical Biochemistry and Nutrition

Volumn 48, Issue 2, 2011, Pages 117-121

  Watanabe, Toshio ^a   Tanigawa, Tetsuya ^a   Nadatani, Yuji ^a   Otani, Koji ^a   Machida, Hirohisa ^a   Okazaki, Hirotoshi ^a   Yamagami, Hirokazu ^a   Watanabe, Kenji ^a   Tominaga, Kazunari ^a   Fujiwara, Yasuhiro ^a   Arakawa, Tetsuo ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aspirin; Mitochondrial permeability transition; Oxidative phosphorylation; Uncoupling

Indexed keywords

2,4 DINITROPHENOL; ACETYLSALICYLIC ACID; BILE ACID; CHENODEOXYCHOLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME C; DICLOFENAC; INDOMETACIN; KETOROLAC; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; REBAMIPIDE; SULINDAC; TUMOR NECROSIS FACTOR ALPHA;

CELL DEATH; CYTOSOL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENTEROBACTERIACEAE; ENZYME INHIBITION; HUMAN; INTESTINE INJURY; INTESTINE ULCER; LOW DRUG DOSE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; REVIEW;

ENTEROBACTERIACEAE;

EID: 79952412935     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.10-73     Document Type: Review

References (44)

1. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992; 327: 749-754.
2. Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy. Nature 2000; 405: 417.
3. Yamamoto H, Sekine Y, Sato Y, and et al. Total enteroscopy with a nonsurgical steerable double-balloon method. Gastrointest Endosc 2001; 53: 216-220. (Pubitemid 32147608)
4. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005; 3: 133-141. (Pubitemid 40220308)
5. Watanabe T, Sugimori S, Kameda N, and et al. Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study. Clin Gastroenterol Hepatol 2008; 6: 1279-1282.
6. Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Gastroenterology 2005; 128: 1172-1178.
7. Sugimori S, Watanabe T, Tabuchi M, and et al. Evaluation of small bowel injury in patients with rheumatoid arthritis by capsule endoscopy: effects of anti-rheumatoid arthritis drugs. Digestion 2008; 78: 208-213.
8. Higuchi K, Umegaki E, Watanabe T, and et al. Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol 2009; 44: 879-888.
9. Higuchi K, Yoda Y, Amagase K, and et al. Prevention of NSAID-induced small intestinal mucosal injury: prophylactic potential of lansoprazole. J Clin Biochem Nutr 2009; 45: 125-130.
10. Tanaka A, Hase S, Miyazawa T, Ohno R, Takeuchi K. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events. J Pharmacol Exp Ther 2002; 303: 1248-1254. (Pubitemid 35424411)
11. Takeuchi K, Tanaka A, Kato S, Amagase K, Satoh H. Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Clin Chim Acta 2010; 411: 459-466.
12. Somasundaram S, Hayllar H, Rafi S, Wrigglesworth JM, Macpherson AJ, Bjarnason I. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroenterol 1995; 30: 289-299.
13. Robert A, Asano T. Resistance of germfree rats to indomethacin-induced intestinal lesions. Prostaglandins 1977; 14: 333-341. (Pubitemid 8171147)
14. Jacob M, Foster R, Sigthorsson G, Simpson R, Bjarnason I. Role of bile in pathogenesis of indomethacin-induced enteropathy. Arch Toxicol 2007; 81: 291-298. (Pubitemid 46434776)
15. Watanabe T, Higuchi K, Kobata A, and et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 2008; 57: 181-187. (Pubitemid 351158044)
16. Watanabe T, Nishio H, Tanigawa T, and et al. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. Am J Physiol Gastrointest Liver Physiol 2009; 297: G506-G513.
17. Zick M, Rabl R, Reichert AS. Cristae formation-linking ultrastructure and function of mitochondria. Biochim Biophys Acta 2009; 1793: 5-19.
18. Sherratt HS. Mitochondria: structure and function. Rev Neurol (Paris) 1991; 147: 417-430.
19. Somasundaram S, Rafi S, Hayllar J, and et al. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine. Gut 1997; 41: 344-353.
20. Ohe K, Hayashi K, Shirakawa T, Yamada K, Kawasaki T, Miyoshi A. Aspirin- and taurocholate-induced metabolic damage in mammalian gastric mucosa in vitro. Am J Physiol 1980; 239: G457-G462. (Pubitemid 11184622)
21. Jorgensen TG, Weis-Fogh US, Nielsen HH, Olesen HP. Salicylate- and aspirin-induced uncoupling of oxidative phosphorylation in mitochondria isolated from the mucosal membrane of the stomach. Scand J Clin Lab Invest 1976; 36: 649-654. (Pubitemid 8021627)
22. Leung WK, Bjarnason I, Wong VW, Sung JJ, Chan FK. Small bowel enteropathy associated with chronic low-dose aspirin therapy. Lancet 2007; 369: 614. (Pubitemid 46241446)
23. Somasundaram S, Sigthorsson G, Simpson RJ, and et al. Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther 2000; 14: 639-650. (Pubitemid 30240758)
24. Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 2007; 20: 1-22. (Pubitemid 46956808)
25. O'Rourke B. Pathophysiological and protective roles of mitochondrial ion channels. J Physiol 2000; 529 Pt 1: 23-36.
26. Scatena R, Bottoni P, Botta G, Martorana GE, Giardina B. The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic. Am J Physiol Cell Physiol 2007; 293: C12-C21. (Pubitemid 47105003)
27. Omatsu T, Naito Y, Handa O, and et al. Reactive oxygen species-quenching and anti-apoptotic effect of polaprezinc on indomethacin-induced small intestinal epithelial cell injury. J Gastroenterol 2010; 45: 692-702.
28. Masubuchi Y, Nakayama S, Horie T. Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats. Hepatology 2002; 35: 544-551. (Pubitemid 34183957)
29. Al-Nasser IA. Salicylate-induced kidney mitochondrial permeability transition is prevented by cyclosporin A. Toxicol Lett 1999; 105: 1-8. (Pubitemid 29090341)
30. Trost LC, Lemasters JJ. Role of the mitochondrial permeability transition in salicylate toxicity to cultured rat hepatocytes: implications for the pathogenesis of Reye's syndrome. Toxicol Appl Pharmacol 1997; 147: 431-441. (Pubitemid 28062760)
31. Lal N, Kumar J, Erdahl WE, and et al. Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress. Arch Biochem Biophys 2009; 490: 1-8.
32. Rolo AP, Oliveira PJ, Moreno AJ, Palmeira CM. Chenodeoxycholate is a potent inducer of the permeability transition pore in rat liver mitochondria. Biosci Rep 2001; 21: 73-80. (Pubitemid 32703515)
33. Gugliucci A, Ranzato L, Scorrano L, and et al. Mitochondria are direct targets of the lipoxygenase inhibitor MK886. A strategy for cell killing by combined treatment with MK886 and cyclooxygenase inhibitors. J Biol Chem 2002; 277: 31789-31795. (Pubitemid 34968984)
34. Scorrano L, Penzo D, Petronilli V, Pagano F, Bernardi P. Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-alpha aopototic signaling. J Biol Chem 2001; 276: 12035-12040.
35. Hayakawa M, Ishida N, Takeuchi K, and et al. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 1993; 268: 11290-11295. (Pubitemid 23162324)
36. Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA, Lemasters JJ. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 1998; 18: 6353-6364. (Pubitemid 28500525)
37. Pastorino JG, Simbula G, Yamamoto K, Glascott PA, Jr., Rothman RJ, Farber JL. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem 1996; 271: 29792-29798. (Pubitemid 26389609)
38. Chan TA, Morin PJ, Vogelstein B, Kinzler KW. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 1998; 95: 681-686. (Pubitemid 28083803)
39. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM. Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 2000; 97: 11280-11285.
40. Watanabe T, Higuchi K, Hamaguchi M, and et al. Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils. Dig Dis Sci 2002; 47: 1582-1589. (Pubitemid 34753939)
41. Watanabe T, Higuchi K, Taira K, and et al. Rebamipide reduces delay in gastric ulcer healing in cyclooxygenase-2-deficient mice. Dig Dis Sci 2005; 50 Suppl 1: S63-S69. (Pubitemid 41380800)
42. Ono S, Kato M, Imai A, and et al. Preliminary trial of rebamipide for prevention of low-dose aspirin-induced gastric injury in healthy subjects: a randomized, double-blind, placebo-controlled, cross-over study. J Clin Biochem Nutr 2009; 45: 248-253.
43. Nagano Y, Matsui H, Muramatsu M, and et al. Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells. Dig Dis Sci 2005; 50 Suppl 1: S76-S83. (Pubitemid 41380802)
44. Niwa Y, Nakamura M, Ohmiya N, and et al. Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study. J Gastroenterol 2008; 43: 270-276. (Pubitemid 351650037)